http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-134615-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ded252b2943e4007e87dbf7d448de74 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 |
filingDate | 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2018e6b9384d477a03473e0d5a9cfd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c804e467d8ef1512ad7d5309b72e8538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00012d61cea59df8734014cdf31c4022 |
publicationDate | 2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RO-134615-A2 |
titleOfInvention | NEW ANALOGS 1 - HOMOCARBONUCLEOSIDES WITH A BICYCLE (2.2.1) HEPTANIC RIGIDIZED FRAGMENT |
abstract | The invention relates to optically active or racemic 1'-homocarbacyclonucleoside analogs with antiviral and / or antitumor action. The derivatives according to the invention contain as heterocyclic base a pyrimidine, 6-chloropurine, adenine or adenine substituted in position 6, and as glycosidic residue a norbornanic radical with specific functionalization, linked to the nitrogen atom N1 or N6 of the base by means of the exocyclic methylene group , having the general formula I, wherein R 1 is H or an ester, ether or silyl ether protecting group. |
priorityDate | 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 504.